Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment.

Stefanie von Matt,Ulrike Bacher,Yara Banz,Behrouz Mansouri Taleghani,Urban Novak,Thomas Pabst

Mediterranean journal of hematology and infectious diseases（2023）

引用 0|浏览14

暂无评分

摘要

Additional therapies can extend OS but mostly cannot prevent death in DLBCL relapsing/refractory post-ASCT. This study may serve as a reference to emerging results after CAR-T treatment in this population.

查看译文

关键词

autologous transplant,lymphoma,b-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要